Page last updated: 2024-08-17

cytidine monophosphate and Granulocytic Leukemia, Chronic, Stable Phase

cytidine monophosphate has been researched along with Granulocytic Leukemia, Chronic, Stable Phase in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
del Cañizo, MC; Fisac, MP; Galende, J; Hurtado, JA; Moro, MJ; Rivas, JM; Rodriguez, JA; Tabernero, MD	1
Abgrall, JF; Attal, J; Bauduer, F; Belhadj, K; Blanc, M; Brière, J; Cambier, N; Chabin, M; Chastang, C; Coso, D; Delain, M; Guerci, A; Guilhot, F; Guilhot, J; Guyotat, D; Harousseau, JL; Ifrah, N; Maloisel, F; Michallet, M; Morice, P; Pegourie-Bandelier, B; Reiffers, J; Rousselot, P; Solary, E; Tertain, G; Vilque, JP	1

Trials

1 trial(s) available for cytidine monophosphate and Granulocytic Leukemia, Chronic, Stable Phase

Article	Year
Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon alpha-2b for the treatment of chronic myelogenous leukemia patients in chronic phase. Leukemia, 2002, Volume: 16, Issue:4 Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Cytidine Monophosphate; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Interferon alpha-2; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Prognosis; Recombinant Proteins; Risk Factors; Survival Rate	2002

Article

Year

Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon alpha-2b for the treatment of chronic myelogenous leukemia patients in chronic phase.

Leukemia, 2002, Volume: 16, Issue:4

Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Cytidine Monophosphate; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Interferon alpha-2; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Prognosis; Recombinant Proteins; Risk Factors; Survival Rate

2002

Other Studies

1 other study(ies) available for cytidine monophosphate and Granulocytic Leukemia, Chronic, Stable Phase

Article	Year
Continuous oral cytarabine ocfosfate with interferon-alpha-2b for patients with newly diagnosed chronic myeloid leukaemia: a pilot study. British journal of haematology, 2001, Volume: 115, Issue:3 Topics: Adolescent; Adult; Aged; Arabinonucleotides; Cytidine Monophosphate; Female; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Pilot Projects; Recombinant Proteins; Treatment Outcome	2001

Article

Year

Continuous oral cytarabine ocfosfate with interferon-alpha-2b for patients with newly diagnosed chronic myeloid leukaemia: a pilot study.

British journal of haematology, 2001, Volume: 115, Issue:3

Topics: Adolescent; Adult; Aged; Arabinonucleotides; Cytidine Monophosphate; Female; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Pilot Projects; Recombinant Proteins; Treatment Outcome

2001